(OSCR) Oscar Health - Ratings and Ratios

Oscar Health Inc. (NYSE:OSCR) is a healthcare technology company that combines advanced technology with a user-centric approach to deliver health insurance plans and related services. The company primarily serves individuals, families, small groups, and Medicare Advantage markets, focusing on simplifying healthcare navigation through its innovative platform.

The companys product suite includes +Oscar, a platform that powers third-party healthcare solutions; Campaign Builder, which offers engagement and recommendation tools for providers and payors; and reinsurance products. Oscar Health Inc. was founded in 2012 as Mulberry Health Inc. and rebranded in 2021, with headquarters in New York, New York.

From a technical standpoint, OSCRs average 20-day volume is 3.8 million shares, with a last price of $12.62. The stock is currently below its 20-day SMA of $12.45 but above the 50-day SMA of $13.68, suggesting a recent dip but potential stabilization. The 200-day SMA stands at $15.98, indicating a longer-term downtrend, with an ATR of $0.80 reflecting moderate volatility.

Fundamentally, Oscar Health has a market cap of $3.01 billion, with a high P/E ratio of 116, suggesting a premium valuation. The forward P/E of 16.31 indicates expected growth. The P/B ratio of 2.87 and P/S of 0.33 suggest the stock may be undervalued relative to revenue, though the RoE of 2.51 is lower than industry averages.

Looking ahead, the 3-month forecast for OSCR may see the stock testing the $13.50 level if it breaks above the 20-day SMA, with potential resistance at $14.50. Support is expected around $11.50. Earnings reports and revenue growth will be critical, with the low P/S ratio suggesting upside potential if the company meets expectations. Moderate volatility is anticipated, with the stocks movement influenced by broader market trends and sector performance.